Related Experiment Videos
[Neoplasms of unknown primary site]
P Khosravi Shahi1, A Del Castillo Rueda, J de Portugal Alvarez
1Servicio de Oncología Médica, Hospital General Univ, Gregorio Marañón, Madrid, Spain.
Anales De Medicina Interna (Madrid, Spain : 1984)
|October 30, 2004
Summary
Neoplasms of unknown primary site (CUP) are diagnosed from metastases. Standard treatment involves empirical chemotherapy, but results vary, necessitating further research for improved outcomes.
Area of Science:
- Oncology
- Pathology
Context:
- Neoplasms of unknown primary site (CUP) present diagnostic challenges, relying on metastatic tissue analysis.
- Established treatment protocols for CUP are limited, impacting patient prognosis.
Purpose:
- To review the diagnostic basis and current therapeutic strategies for neoplasms of unknown primary site.
- To highlight the variability in treatment outcomes for CUP.
Summary:
- CUP are identified through pathological examination of metastatic lesions.
- Current standard treatment typically involves empirical chemotherapy, often utilizing taxanes and platinum compounds.
- Treatment efficacy and patient outcomes demonstrate significant variability across studies.
Impact:
- This review underscores the need for refined diagnostic and therapeutic approaches for CUP.
- Improved understanding can lead to more personalized and effective cancer treatment strategies.